Latest Breaking News On - Martin dow - Page 11 : comparemela.com
Citi Pharma to raise up to Rs2 8billion in IPO
dailytimes.com.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailytimes.com.pk Daily Mail and Mail on Sunday newspapers.
In-person commencement returns at Fort Lewis College
durangoherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from durangoherald.com Daily Mail and Mail on Sunday newspapers.
Search jobs 04-May-2021 Injectable Benzodiazepine Market 2021 Analysis By Regional, Outlook, Competitive Landscape Strategies And Forecast 2030 | Akorn Inc, Pfizer Inc., AdvaCare Pharma, Dash Pharmaceuticals LLC & so on…
Future Market Insight’s projections reveal that the global injectable benzodiazepine market is set to shoot up significantly in 2020, reaching a value of US$ 260 Mn in the wake of the coronavirus pandemic.
Benzodiazepines are a class of psychoactive drugs used to reduce anxiety amongst patients. As the pandemic tightens its grip each day, stress levels among individuals regarding the threat is increasing. Massive layoffs from jobs across various industries due to lockdowns is leading to increased cases of depression. Without jobs, people are unable to sustain their families, which is putting enormous strain on their mental and physical well-being. Therefore, consumption of anti-depressant drugs containing ben
Interview: Javed Ghulam Mohammad, Group MD & CEO, Martin Dow Group - Recent
dawn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dawn.com Daily Mail and Mail on Sunday newspapers.
Citi Pharma Ltd., a raw material supplier to the Pakistani units of GlaxoSmithKline Plc and Abbott Laboratories, is planning to opt for an initial public offering (IPO) in the Pakistan Stock Exchange (PSX), Bloomberg reported on Friday.
Chief Executive Officer (CEO), Rizwan Ahmad informed the media that the Lahore-based company aims to raise Rs. 2.85 billion ($18 million) within the next month and a half, in what might be the biggest share listing in Pakistan by a pharmaceutical company.
ALSO READ
The initial public offer will include 35 percent of the company’s equity or 72.7 million shares at Rs. 28 per share with an upper limit of 40 percent, according to the financial adviser for the IPO, Topline Securities Pakistan Ltd.